TROY, Mich., July 21, 2026 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of

Baader Bank Aktiengesellschaft decreased its stake in shares of ResMed Inc. (NYSE: RMD) by 61.7% in

Mizuho analyst Anthony Petrone maintains ResMed (NYSE:RMD) with a Outperform and lowers the price

Wall Street analysts change outlook on top names. Complete view of analyst rating changes including

Citigroup analyst Laura Sutcliffe downgrades ResMed (NYSE:RMD) from Buy to Neutral and lowers the

Jefferies analyst Matthew Taylor maintains ResMed (NYSE:RMD) with a Hold and lowers the price tar

ResMed is selling MatrixCare for $490 million to sharpen its sleep health focus as analysts weigh ne

RBC Capital analyst Craig Wong-Pan maintains ResMed (NYSE:RMD) with a Outperform and lowers the p

Wells Fargo analyst Nathan Treybeck maintains ResMed (NYSE:RMD) with a Equal-Weight and lowers th

On July 7, 2026, ResMed Inc. (the "Company" or "Resmed") issued a press release anno

Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and

Keybanc analyst Justin Patterson maintains ResMed (NYSE:RMD) with a Overweight and lowers the pri

Top analysts changed outlook on top names: Intuit downgraded, Alkermes price target raised, Carmax t

Wall Street analysts changed outlook on top names. Check analyst ratings page for upgrades, downgrad

Top Wall Street analysts changed outlook on top names. Baird raised prices for Ryder System and J

Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that

A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.

  During the session on Thursday, 461 stocks hit new 52-week lows.

    Before 10 a.m. ET on Tuesday, 125 stocks hit new 52-week highs.

  Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings